182 related articles for article (PubMed ID: 24518496)
1. A meta-analysis on the role of rectal diclofenac and indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Sethi S; Sethi N; Wadhwa V; Garud S; Brown A
Pancreas; 2014 Mar; 43(2):190-7. PubMed ID: 24518496
[TBL] [Abstract][Full Text] [Related]
2. NSAIDs do not reduce severity among post-ERCP pancreatitis patients.
El Kurdi B; Imam Z; Abonofal A; Babar S; Shah P; Pannala R; Papachristou G; Echavarria J; Pisipati S; Jahangir S; Rajalingamgari P; Chang YH; Singh VP
Pancreatology; 2024 Feb; 24(1):14-23. PubMed ID: 37981523
[TBL] [Abstract][Full Text] [Related]
3. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
[TBL] [Abstract][Full Text] [Related]
4. Effect of rectal indomethacin on the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography for choledocholithiasis: a prospective randomized clinical trial.
Liu KJ; Hu Y; Guo SB
Rev Esp Enferm Dig; 2024 Apr; 116(4):20-208. PubMed ID: 37982566
[TBL] [Abstract][Full Text] [Related]
5. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial Effect of Prophylactic Interventions for Post-ERCP Pancreatitis among Patients with Risk Factors: A Network Meta-Analysis.
Choi JH; Lee SH; Kim JS; Park N; Lee MH; Lee MW; Cho IR; Paik WH; Ryu JK; Kim YT
Gut Liver; 2023 Sep; 17(5):814-824. PubMed ID: 36510779
[TBL] [Abstract][Full Text] [Related]
7. Rectally administered indomethacin to prevent post-ESWL-pancreatitis (RIPEP): study protocol for a randomized controlled trial.
Qian YY; Chen H; Tang XY; Jiang X; Qian W; Zou WB; Xin L; Li B; Qi YF; Hu LH; Zou DW; Jin ZD; Wang D; Du YQ; Wang LW; Liu F; Li ZS; Liao Z
Trials; 2017 Nov; 18(1):513. PubMed ID: 29096689
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of nafamostat mesylate in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of randomized controlled trials.
Narumi K; Okada T; Lin Y; Kikuchi S
Sci Rep; 2023 Dec; 13(1):23012. PubMed ID: 38155200
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial.
Yared RA; Chen CC; Vandorpe A; Arvanitakis M; Delhaye M; Viesca MFY; Huberty V; Blero D; Toussaint E; Hittelet A; Verset D; Margos W; Le Moine O; Njimi H; Liao WC; Devière J; Lemmers A
Pancreatology; 2024 May; 24(3):363-369. PubMed ID: 38431445
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Stent or Rectal Indomethacin-Which Better Prevents Post-ERCP Pancreatitis?: A Propensity Score Matching Analysis.
Li GD; Jia XY; Dong HY; Pang QP; Zhai HL; Zhang XJ; Guo R; Dong YC; Qin CY
Medicine (Baltimore); 2016 Mar; 95(10):e2994. PubMed ID: 26962808
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis.
Rojas-Victoria EJ; Hernández-Ruiz SI; García-Perdomo HA
Expert Rev Gastroenterol Hepatol; 2024; 18(4-5):203-215. PubMed ID: 38725175
[TBL] [Abstract][Full Text] [Related]
12. Nafamostat Reduces the Incidence of post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Horváth IL; Kleiner D; Nagy R; Fehérvári P; Hankó B; Hegyi P; Csupor D
Clin Pharmacol Ther; 2024 Feb; 115(2):206-212. PubMed ID: 38032816
[TBL] [Abstract][Full Text] [Related]
13. Rectal administration of tacrolimus protects against post-ERCP pancreatitis in mice.
Lin YC; Ni J; Swaminathan G; Khalid A; Barakat MT; Frymoyer AR; Tsai CY; Ding Y; Murayi JA; Jayaraman T; Poropatich R; Bottino R; Wen L; Papachristou GI; Sheth SG; Yu M; Husain SZ
Pancreatology; 2023 Nov; 23(7):777-783. PubMed ID: 37778935
[TBL] [Abstract][Full Text] [Related]
14. Does rectal diclofenac reduce post-ERCP pancreatitis? A district general hospital experience.
Sheiybani G; Brydon P; Toolan M; Linehan J; Farrant M; Colleypriest B
Frontline Gastroenterol; 2018 Jan; 9(1):73-77. PubMed ID: 29484164
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs before endoscopic ultrasound guided tissue acquisition to reduce the incidence of post procedural pancreatitis.
de Jong M; van Delft F; Roozen C; van Geenen EJ; Bisseling T; Siersema P; Bruno M
World J Gastroenterol; 2024 Feb; 30(8):811-816. PubMed ID: 38516233
[TBL] [Abstract][Full Text] [Related]
16. Role of Rectal Diclofenac Suppository for Prevention and Its Impact on Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients.
Patil S; Pandey V; Pandav N; Ingle M; Phadke A; Sawant P
Gastroenterology Res; 2016 Jun; 9(2-3):47-52. PubMed ID: 27785324
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different nonsteroidal anti-inflammatory drugs for cesarean section: a systematic review and network meta-analysis.
Murdoch I; Carver AL; Sultan P; O'Carroll JE; Blake L; Carvalho B; Onwochei DN; Desai N
Korean J Anesthesiol; 2023 Dec; 76(6):597-616. PubMed ID: 37066603
[TBL] [Abstract][Full Text] [Related]
18. Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial.
Machicado JD; Mounzer R; Paragomi P; Pothoulakis I; Hart PA; Conwell DL; de-Madaria E; Greer P; Yadav D; Whitcomb DC; Lee PJ; Hinton A; Papachristou GI
Clin Transl Gastroenterol; 2021 Oct; 12(11):e00415. PubMed ID: 34704970
[TBL] [Abstract][Full Text] [Related]
19. Does indomethacin reduce the risk of thromboembolic events in patients undergoing ERCP?
Wu J; Ding H; Mei Q
Gastrointest Endosc; 2024 May; 99(5):862. PubMed ID: 38649226
[No Abstract] [Full Text] [Related]
20. ORAL N-ACETYL CYSTEINE VERSUS RECTAL INDOMETHACIN FOR PREVENTION OF POST ERCP PANCREATITIS: A MULTICENTER MULTINATIONAL RANDOMIZED CONTROLLED TRIAL.
Alavinejad P; Tran NN; Eslami O; Shaarawy OE; Hormati A; Seiedian SS; Parsi A; Ahmed MH; Behl NS; Abravesh AA; Tran QT; Vignesh S; Salman S; Sakr N; Ara TF; Hajiani E; Hashemi SJ; Patai ÁV; Butt AS; Lee SH
Arq Gastroenterol; 2022 Nov; 59(4):508-512. PubMed ID: 36383882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
